These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Diagnosis and treatment of malignant pancreatic endocrine tumour.
    Author: Wang L, Zhao YP, Lee CI, Liao Q.
    Journal: Chin Med Sci J; 2004 Jun; 19(2):130-3. PubMed ID: 15250251.
    Abstract:
    OBJECTIVE: To summarize our experience in the diagnosis and treatment of malignant pancreatic endocrine tumour. METHODS: We retrospectively reviewed 36 cases of malignant pancreatic endocrine tumours in our hospital from July 1987 to April 2002, and summarized its clinical features. RESULTS: Liver metastasis was the main malignant manifestation of malignant pancreatic endocrine tumours (incidence rate 72.2%). Removals of primary lesion and isolated hepatic metastatic lesion were means of curative therapy. Interventional chemotherapy was an important adjuvant treatment. CONCLUSION: Comprehensive therapy plays an important role in improving the prognosis of malignant pancreatic endocrine tumour.
    [Abstract] [Full Text] [Related] [New Search]